Stockholders elect all three Class II directors, ratify auditor, approve say-on-pay, set frequency to one year

Mirum Pharmaceuticals, Inc.

Elected Laurent Fischer, Patrick Heron, and Saira Ramasastry as Class II directors (each received >19M votes for).
Ratified Ernst & Young as independent auditor for FY2024 (37.5M for, 36k against, 143k abstain).
Advisory approval of executive compensation: 32.7M for, 1.1M against, 90k abstain.
Advisory vote on say-on-pay frequency: 33.8M for one year; board adopts annual frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.